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Background:  Patients  with  non-ST-elevation  acute  coronary  syndrome  are  heterogeneous  in  terms  of
clinical  presentation  and immediate-  and  long-term  risk  of death  or non-fatal  ischemic  events.  The  aim  of
the  present  study  was  to evaluate  the  relationship  between  the  Global  Registry  of Acute  Coronary  Events
(GRACE)  score  and  severity  of  coronary  artery  disease  angiographically  evaluated  by Gensini  score  in
patients  with  non-ST-elevation  acute coronary  syndrome.
Methods: A  total  of 245  patients  with  non-ST-elevation  acute  coronary  syndrome  were  enrolled  to  the
study.  Based  on  the  GRACE  risk score  classiﬁcation  system,  the  patients  were  divided  into  low-  (n =  97,
39.6%),  intermediate-  (n = 84, 34.3%),  and  high-  (n =  64, 26.1%)  risk  groups.  All  patients  underwent  coro-
nary  angiography  within  ﬁve  days  after  admission.
Results: The  Gensini  scores  were  26  ±  29  in the  low-risk  group,  29  ±  19  in  the intermediate-risk  group,  and
38  ± 23  in the high-risk  group  (p  = 0.016).  The  low-risk  group  was  signiﬁcantly  different  from  the  high-
risk  group  (p =  0.013),  and  the  difference  from  the  intermediate-risk  group  almost  reached  signiﬁcance.
Normal,  noncritical,  one  and  two,  or multivessel  disease  were  identiﬁed  in 15 (6.1%), 31  (12.7%),  75
(30.6%),  and  124  (50.6%)  patients,  respectively.  The  prevalence  of  multivessel  disease  was  28%  in  the
low-risk  group,  30%  in the  intermediate-risk  group,  and  42%  in  the  high-risk  group.  The high-risk  group
was  signiﬁcantly  different  from  the low-risk  group  (p  < 0.01).
Conclusion: Our  study  demonstrates  that  the GRACE  score  has signiﬁcant  value  for assessing  the  severity
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Patients with non-ST-elevation acute coronary syndrome
NSTE-ACS) are heterogeneous in terms of clinical presentation
nd immediate- and long-term risk of death or non-fatal ischemic
vents [1,2]. Early risk stratiﬁcation plays a pivotal role in the
ptimal management of NSTE-ACS which represents variable
hort-term and long-term prognostic features [3–5]. Based on the
valuation encompassing medical history, physical examination,
lectrocardiography (ECG), and biochemical markers, several clas-
iﬁcations have been recommended for the identiﬁcation of the risk
nd selection of the management strategy in patients with NSTE-
CS [6,7]. Global Registry of Acute Coronary Events (GRACE) risk
core and Thrombolysis in Myocardial Infarction (TIMI) risk scores
re widely used for risk stratiﬁcation in NSTE-ACS; however, sev-
ral reports have shown that GRACE score is a better predictor of
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clinical outcome than TIMI score [8–11]. GRACE score is a predic-
tive logistical model which uses 8 prognostic variables (Table 1).
Values for these variables can be entered into the GRACE risk cal-
culator to derive a prognostic score that will estimate the risk of
death or the combined risk of death or myocardial infarction at 6
months in individual patients.
The extent and severity of atherosclerotic disease of coro-
nary arteries are highly variable. However, it is unknown whether
GRACE score is useful in predicting the severity of lesions assessed
by coronary angiography in patients with NSTE-ACS. The aim of
the present study was  to evaluate the relationship between GRACE
score and severity of coronary artery disease (CAD) angiographi-
cally evaluated by Gensini score in patients with NSTE-ACS.
Patients and methodsA  total of 356 patients were admitted to the emergency
department of our institution with NSTE-ACS in 2011. NSTE-
ACS was diagnosed by presence of at least one of these criteria:
Unstable angina pectoris within the past 48 h, positive cardiac
vier Ltd. All rights reserved.
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Table  1
GRACE risk score parameters.
Age (years)
<40 0
40–49 18
50–59 36
60–69 55
70–79 73
80 91
Heart rate
<70  0
70–89 7
90–109 13
110–149 23
150–199 36
>200 46
Systolic blood pressure (mmHg)
<80 63
80–99 58
100–119 47
120–139 37
140–159 26
160–199 11
>200 0
Creatinine (mg/dL)
0–0.39  2
0.4–0.79 5
0.8–1.19 8
1.2–1.59 11
1.6–1.99 14
2–3.99 23
>4 31
Killip class
Class I 0
Class II 21
Class III 43
Class IV 64
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aCardiac arrest at admission 43
Elevated cardiac markers 15
ST-segment deviation 30
iochemical markers (creatine kinase-myocardial band or cardiac-
peciﬁc troponin I), and ischemic ECG changes without new
T-segment elevation. Patients with previous coronary artery
ypass graft (CABG), percutaneous coronary intervention (PCI),
yocardial infarction (MI), and who did not accept coronary
ngiography were excluded from the study and the remaining 245
atients were included in the study.
For each patient, GRACE score was calculated by using speciﬁc
ariables collected at admission. Patients were classiﬁed into 3
ategories low (1–108), intermediate (109–140), and high (>140),
ccording to the GRACE score. All patients underwent emergency,
arly or elective coronary angiography within 5 days of admission
mean 3 days). Gensini scoring system was used to evaluate the
everity and extent of coronary stenotic lesions.
oronary angiography and Gensini score
Selective coronary angiography was performed in all patients
sing the Judkins technique. Left and right coronary angiographies
ere performed at various projections. Assessment of coronary
tenosis by coronary angiography was by 2 experienced cardio-
ogists and Gensini score was calculated for each patient according
o coronary angiography results [12,13].
The score was computed by assigning a severity score to each
oronary stenosis according to the degree of luminal narrowing and
ts geographic importance. Reduction in the lumen diameter, and
he roentgenographic appearance of concentric lesions and eccen-
ric plaques were evaluated (reductions of 25%, 50%, 75%, 90%, 99%,
nd complete occlusion, were given Gensini scores of 1, 2, 4, 8, 16,
nd 32, respectively). Each principal vascular segment was  assigned
 multiplier in accordance with the functional signiﬁcance of thediology 63 (2014) 24–28 25
myocardial area supplied by that segment: the left main coronary
artery × 5; the proximal segment of left anterior descending coro-
nary artery (LAD) × 2.5; the proximal segment of the circumﬂex
artery × 2.5; the mid-segment of the LAD × 1.5; the right coronary
artery, the distal segment of the LAD, the posterolateral artery, and
the obtuse marginal artery × 1; and others × 0.5.
Stenosis  reducing the intraarterial diameter of greater than 50%
was regarded as hemodynamically signiﬁcant. Noncritical coronary
artery disease was  deﬁned as a < 50% stenosis in coronary arteries.
Single-vessel disease was  deﬁned as a ≥50% stenosis in only one
major epicardial artery or an important branch of a major epicardial
coronary artery. Multivessel coronary disease deﬁned as the pres-
ence of a > 50% stenosis in two or more major epicardial arteries or
left main coronary artery disease.
Statistical analyses
Statistical analyses were performed using SPSS for Windows
17.0 (SPSS Inc., Chicago, IL, USA). Data are presented as frequen-
cies and percentages for categorical variables and mean ± standard
deviation (SD) for continuous variables, unless otherwise indicated.
For numerical variables, an independent sample t test were used
for intergroup comparisons. One way ANOVA test was  used for sta-
tistical comparison of continuous variables between the groups.
Chi-square test was used for comparison of categorical variables
between the groups. A multiple linear regression analysis was per-
formed to evaluate the effects of the various variables, diabetes
mellitus (DM), hypertension (HT), body mass index (BMI), smok-
ing, and left ventricular ejection fraction (LVEF) on the severity
of CAD, as deﬁned by the Gensini score. The correlation between
the GRACE score and Gensini score was  examined with Pearson
correlation analysis. The receiver operating characteristic (ROC)
curve was used to predict left main or three-vessel and multivessel
disease.
Results
Clinical characteristics
The  present analysis includes a total of 245 patients (65 women
and 180 men). Mean age was  61 ± 12 years. Based on the GRACE
risk score classiﬁcation system, the patients were divided as low-
(n = 97, 39.6%), intermediate- (n = 84, 34.3%), and high- (n = 64,
26.1%) risk groups. Clinical and laboratory parameters of the three
GRACE groups are shown in Table 2. The mean ages were 51 ± 7,
62 ± 10, and 73 ± 8 years in groups low, intermediate, and high,
respectively. The groups did not differ in terms of coronary heart
disease risk factors including BMI, smoking, and diabetes mellitus.
But there was  a signiﬁcant difference in hypertension (p = 0.016)
and LVEF (p < 0.01) between the GRACE groups. The difference was
signiﬁcant between the low-risk GRACE group and high-risk GRACE
group. Using ANOVA as the test of signiﬁcance, the mean angi-
ographic Gensini scores showed increasing trend from lower to
higher GRACE risk groups (p = 0.013). Distribution of Gensini score
according to the GRACE score is presented in Fig. 1.
Based on Gensini scoring, linear regression analysis conﬁrmed
that GRACE score was a strong predictor for CAD severity in the
presence of other risk factors. GRACE score showed signiﬁcant cor-
relation with respective angiographic Gensini scores by Pearson’s
correlation (2-tailed) (r = 0.189, p = 0.03).
Multiple linear regression analysis revealed that some fac-
tors that are not included in GRACE score have inﬂuence on
Gensini score. The results were as follows: DM (  ˇ = 0.188, p = 0.006),
LVEF (  ˇ = −0.129, p = 0.040), HT (  ˇ = −0.036 p = 0.606), smoking
(  ˇ = 0.141, p = 0.029), and BMI  (  ˇ = −0.097, p = 0.127).
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Table  2
Comparison of demographic data of groups.
Variable Low-risk group
(1–108)
Intermediate-risk group
(109–140)
High-risk group
(>140)
p
Mean age (years) 51 ± 7 62 ± 10 73 ± 8
GRACE score 87 ± 14 124 ± 8 168 ± 26
Body mass index 25.5 ± 3 26 ± 2.9 25.4 ± 2.9 0.34
Smoking,  n (%) 46 (47.4%) 40 (47.6%) 26 (40.6%) 0.396
Hypertension prevalence, n (%) 48 (49.5%) 50 (59.5%) 44 (68.8%) 0.016
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Gensini  score 26 ± 29
Left  ventricular ejection fraction (%) 49 ± 9 
The area under the ROC curve of GRACE score for predicting left
ain or three-vessel disease was 0.65 (95%CI 54–76, p = 0.012) and
.72 (95% CI 64–80, p = 0.001) for multivessel disease.
ngiographic results
We  classiﬁed angiograms as emergent (within 2 h), early (within
rst 2 days), and elective (>2 days). A total of 22 patients (8.9%) were
n the emergent group, 176 patients (71.8%) were in the early group,
nd 47 patients (19.3%) were in the elective angiogram group. Vis-
ble thrombus was seen on the initial angiogram in 9.7% (24) of all
atients. These were distributed among the groups as 3.6%, 4%, and
% emergent, early, and elective, respectively.
Gensini scores were 26 ± 29 in the low-risk group, 29 ± 19
n the intermediate-risk group, and 38 ± 23 in the high-risk
roup (p = 0.016). The low-risk group was signiﬁcantly different
rom the high-risk group (p = 0.013) and the difference from the
ntermediate-risk group almost reached signiﬁcance (p = 0.702).
Normal, noncritical, one and two, or multivessels disease were
dentiﬁed in 15 (6.1%), 31 (12.7%), 75 (30.6%), and 124 (50.6%)
atients, respectively. The prevalence of multivessel disease was
8% in the low-risk group, 30% in the intermediate-risk group, and
2% in the high-risk group. The high-risk group was signiﬁcantly
ifferent from the low-risk group (p < 0.01). Moreover, 51 (20.8%)
atients had three-vessel or left main coronary artery (LMCA) dis-
ase. Three-vessel or LMCA disease was present in 15 patients
15.5%) in the low-risk group, 17 (20.2%) in the intermediate-risk
roup, and 19 (29.7%) in the high-risk group. The high-risk group
as signiﬁcantly different from the low-risk group (p = 0.042).
Seventy-three patients were diabetic (29.8%), two of them
ad normal coronary arteries (2.7%) and forty-nine had
Fig. 1. Gensini score distribution of patients according to GRACE score. (29.8%) 24 (37.5%) 0.083
 ± 19 37 ± 23 0.013
 ± 1 42 ± 6 <0.001
multivessel disease (67.1%). Subgroup analysis of our study
suggested that patients with diabetes had higher Gensini scores
than non-diabetics (36.9 ± 30 vs. 27.4 ± 22.3, p = 0.015).
We  report clinical outcomes of PCI, CABG, and medical treat-
ment in NSTE-ACS during hospitalization. In the low GRACE group,
58 patients (59.8%) had PCI, 21 patients (21.6%) had CABG, and
18 patients (18.6%) had medical treatment. In the intermediate
GRACE group 42 patients (50%) had PCI, 29 patients (34.5%) had
CABG, and 13 patients (15.5%) had medical treatment. In the high
GRACE group, 24 patients (37.5%) had PCI, 26 patients (40.6%) had
CABG, and 14 patients (21.9%) had medical treatment. There were
no deaths during hospitalization. The rate of reinfarction or revas-
cularization was  2.1%, 3.8%, and 6.7% in the low-, intermediate-, and
high-risk groups, respectively.
Interobserver  correlation coefﬁcient of the Gensini score of
20 randomly selected patients was 0.96 for the interpretation of
angiograms. Intra-observer variability was 0.98.
Discussion
To the best of our knowledge, our study is the ﬁrst to suggest that
a high GRACE score is associated with an increase in the severity
of CAD deﬁned by the Gensini score in patients with NSTE-ACS.
Our results showed that GRACE score has signiﬁcant relation with
the extent and severity of CAD as assessed by angiographic Gensini
score.
Risk stratiﬁcation is synonymous with prognosis determina-
tion. It is important during hospitalization and after discharge. Use
of the GRACE score for stratifying risk in NSTE-ACS was recom-
mended by clinical practice guidelines. Management decisions in
NSTE-ACS should be based on a rapid and accurate assessment of
risk. Patients who  have the highest risk will have the poorest prog-
nosis. The GRACE score provides an estimate of the probability of
death within 6 months after hospital discharge in patients with
NSTE-ACS [14–16].
Several  studies have deﬁned the relationship between coronary
artery risk factors and severity of coronary artery lesions. Some risk
factors may  inﬂuence the development of coronary atherosclerosis
at different levels of its evolution. There are different opinions about
which stage of atherosclerosis is affected by DM and HT. Although
some studies suggesting that HT and DM may  affect early stages
of atherosclerosis, other results do not support that idea [17–22].
Additionally, renal function is also an important predictor of the
presence and severity of angiographic CAD and creatinine level
has an incremental value over traditional CAD risk factors [23–25].
The increased prevalence of atherosclerotic coronary stenoses with
the progression of age in both sexes has also been reported before
in autopsy studies. The rate of this increase was, however, more
prominent in men  between 30 and 49 years of age, whereas a
steady increase by age was encountered in women [26]. Recent data
demonstrated a signiﬁcant positive correlation between coronary
angiographic scores and age, creatinine level, DM, and smoking, but
not with blood pressure [27]. In the present study, CAD risk factors
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ot included in GRACE score such as DM and smoking were found
o be correlated with Gensini score, but HT and BMI  were not. In
ur study, Gensini score was 33 ± 24 in patients over 55 years of
ge and 26 ± 25 in patients under the age of 55 and the difference
etween these two groups was statistically signiﬁcant (p = 0.032).
Our study showed normal coronary arteries and noncritical CAD
ere more often found in patients in the low-risk group by GRACE
core, and three-vessel or left-main lesions of coronary artery were
ore often found in patients in the high-risk group by GRACE
core. Speciﬁcally, low-risk patients are more likely to have nor-
al coronary arteries or noncritical CAD, whereas intermediate
nd high-risk patients are more likely to have signiﬁcant CAD (>2
essels, or left main CAD). In other words, the GRACE score is also
mportant for determining the severity of the CAD beside predicting
eath within 6 months of hospital discharge.
We found that Gensini score was positively and signiﬁcantly
ssociated with the GRACE score. The signiﬁcant linear relation-
hip between Gensini score and GRACE score is reported in Fig. 2
r = 0.189, p = 0.03). With the increased GRACE score, Gensini score
ncreases demonstrating more severe coronary atherosclerosis.
Mehta et al. grouped the non ST elevation myocardial infarction
atients into an early intervention group (coronary angiography
24 h after randomization) or a delayed-intervention group (coro-
ary angiography ≥36 h after randomization). The comparison of
hese groups showed that early intervention appeared to provide a
igniﬁcant beneﬁt in the prevention of death, myocardial infarction,
nd stroke especially in patients in the high-risk category according
o GRACE score [28]. In patients at low-to-intermediate risk, out-
omes between the two strategies appeared to be almost identical.
oreover, this observation builds on current guidelines for patients
ith ACS that recommend risk stratiﬁcation for all such patients.
he guidelines also suggest that in high-risk patients, interven-
ion within 24 h is superior to a strategy of delaying intervention
o more than 36 h [29]. In general, according to the results of the
resent study, patients with high GRACE score have more severe
AD, therefore angiography is important in the ﬁrst 24 h for early
ntervention in these patients.
imitations of the studyThere  are two limitations to this study. Normal coronary arteries
ere described by coronary angiography; intravascular ultrasono-
raphy was not used. Secondly, the number of patients in our study
as relatively small.
Fig. 2. The positive correlation between Gensini score and GRACE score.
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In conclusion, our study demonstrates that the GRACE score
has signiﬁcant value for assessment of severity and extent of the
coronary artery stenosis in patients with NSTE-ACS. Nevertheless,
further studies with large numbers of patients are needed to con-
ﬁrm this conclusion.
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